Youngwook Kim

YoungWook Kim serves as the Associate Director of Investigator Engagement for Korea within the Clinical Research Investigator Engagement, Delivery & Capabilities at Eli Lilly and Company. In this role, he is entrusted with the comprehensive oversight of investigator site management for clinical research across Lilly Korea. His responsibilities encompass a broad range of critical capabilities, including portfolio management, study feasibility assessment, site selection, patient enrollment, and monitoring.

Holding a Bachelor’s degree in Pharmacy from Sahmyook University, he has cultivated a distinguished career that spans over 15 years in the pharmaceutical industry, with a particular focus on clinical operations. His professional journey has seen him undertake various roles, from CRA to Clinical Development Consultant, Clinical Operations Portfolio Manager, Clinical Information Process Automation, and Clinical Project Management. His experience covers a diverse geographical spectrum, including Korea, Emerging Markets, and Lilly Headquarters.

His extensive experience and deep commitment to the field are driven by a passion for enhancing the delivery of clinical research, with the ultimate goal of improving patient outcomes and advancing healthcare. His expertise and dedication are reflected in his approach to fostering innovation and efficiency in clinical research processes.

Maggie Lim

Maggie LIM has been in the clinical research industry for the last 26 years; she graduated from Singapore National University Pharmacy and took up Clinical Pharmacy postgraduate in Canberra Australia while working as a pharmacist in Singapore General Hospital.
She took an interest in Clinical Research and joined Eli Lilly as a CRA and study manager, specializing in early phase clinical pharmacology studies.
When the opportunity came to join GSK as a regional Asia-Pacific GCP trainer came in 2007, she covered training for R&D medical and clinical teams for 5 years before joining Global Clinical Quality Assurance in 2012,  and has since been managing a team of auditors delivering the QA strategized audits for the region.

SeungWoo Shin

Education

1999.03 ~ 2005. 08 Ph.D., Department of Computer Engineering, Kyungpook National University
1997. 03 ~ 1999. 02 M.S., Department of Computer Engineering, Kyungpook National University

Professional Experiences

2021. 12 ~

2018. 12 ~ 2021. 12

2009. 03 ~ 2018.12

Daewoong Pharmaceutical / AI New Drug Discovery team leader

Syntekabio / AI New Drug Discovery team leader

SOONCHUNHYANG UNIVERSITY HOSPITAL / Academic Research Professor

2007.4 ~ 2009.2

2005.10~ 2007.03

Korea Institute for Advanced Study (KIAS) / Senior Researcher

Korea National Institute of Health, Genomics Research Center, Bioscience information team / Senior Researcher

Publications (Selected or Past 5 years)

○ A new algorithm for detecting Low-complexity regions in protein sequences, bioinformatics, pp 160-170, vol. 21, 2005

○ Asthma-Predictive Genetic Markers in Gene Expression Profiling of Peripheral Blood

Mononuclear Cells, ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, pp 265-272, vol. 3, 2011

○ Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene

marker for AERD, Molecular Genetics and Genomics, pp 361-371, vol 287, 2012

○   A Highly Sensitive and Specific Genetic Marker to Diagnose Aspirin-Exacerbated Respiratory Disease Using a Genome-Wide Association Study, DNA AND CELL BIOLOGY, p1604-1609, vol 31, 2012

○ Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean

population, Hum Genet, March 2013, Volume 132, Issue 3, pp 313–321

○ Elevation of Eosinophil-Derived Neurotoxin in Plasma of the Subjects with Aspirin-Exacerbated Respiratory Disease: A Possible Peripheral Blood Protein Biomarker, PLOS ONE, vol 8, 2013.

○ Exonic Variants Associated with Development of Aspirin Exacerbated, Respiratory Diseases,

PLOS ONE 9(11), 2014.

○ Genome wide identification and expression profile in epithelial cells exposed to TiO₂ particles, Environ Toxicol, 2015 Mar;30(3):293-300

○ Association between TAAR6 polymorphisms and airway responsiveness to inhaled

corticosteroids in asthmatic patients, Pharmacogenetic Genomics, 2015 Jul;25(7):334-42

○ Development of a genetic marker set to diagnose aspirin-exacerbated respiratory disease     in a genome-wide association study, Pharmacogenomics J. 2015 Aug;15(4):316-21

○ Clinical Characteristics of Exacerbation-Prone Adult Asthmatics Identified by Cluster

Analysis, Allergy Asthma Immunol Res, 2017 Nov;9(6):483-490

○ lung function trajectory types in never-smoking adults with asthma: clinical features and

inflammatory patterns, Allergy Asthma Immunol Res. 2018 Nov;10(6):614-627

 

Seongyun Bang

She has been an expert in drug development, clinical trials, projects, and quality control since 2001 and has worked in domestic pharmaceutical companies and global CRO, as well as university. She graduated from Seoul National University with B.S and Doctor degree and obtained Ph.D. from the CHA university.

And she served as a branch manager(country head), global task manager and quality manager in a Global CRO, PAREXEL International and as a professor at the University of CHA univeristy for five years from 2014, she has served as the head of the New Drug Development Division at Bioteches since 2020. she is currently leading clinical development as the head of development and vice president of Spark Biopharma.

Suntae Kim

Director, Clinical Development, Connext Co. Ltd.

 

Previously worked as CDO, MedGene Therapeutics Inc.;

Project Manager & Senior Director, KCRN Research;

Principal Scientist, G+FLAS Lifesciences;

Postdoc & Research Fellow, NCI, NIH;

Ph.D. in Biochemistry & Molecular Biology, Environmental Toxicology, Michigan State University;

BS & MS, Seoul National University

HyeJung Yang

Hyejung Yang is the Clinical Research Manager and Clinical Research Team Lead at MedPacto Inc,. She has almost 12 years of experience in Clinical Research Project management by local pharmaceutical companies.

 

Baek-Jae KIM

BJ (Baek-Jae) Kim, Ph.D., is the IATA Country Manager Korea, based in Seoul, Republic of Korea. BJ leads a team of 3 (Mr. HT Lee, Ms. Anna Park, and Ms. Hyein Jeon) in the Korea field office work.

Prior to joining IATA in Aug 2019, BJ has about 25 years of aviation experience, including 6 years in United Airlines, 4 years in Air France, and 16 years in Qatar Airways as Airport Services Manager in ICN airport, the Republic of Korea.

BJ holds a Ph.D. and Master of Aviation Business Administration from the Korea Aerospace University (KAU) and a Bachelor’s degree in Economics from Hankuk University of Foreign Studies (HUFS) in the Republic of Korea.

BJ is a citizen of the Republic of Korea. He is a Christian and married with 2 children. BJ enjoys hiking, mountain climbing, and other sports in his spare time.